New HCPCS coding changes for intermittent catheters take effect Jan. 1, 2026, and there are steps providers can take now to ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that a specific Healthcare Common Procedure Coding System (HCPCS) ...

The FDA revised its emergency use authorization for EVUSHELD™, tixagevimab co-packaged with cilgavimab. The initial dose authorized has been changed to 600 mg for pre-exposure prevention of COVID-19.

The Medicare Inpatient Only (IPO) list details the procedures that Medicare will cover in an inpatient setting. The Centers for Medicare & Medicaid Services (CMS) releases the IPO list each year. The ...

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...